Volitionrx (VNRX) Other financing activities (2019 - 2025)

Volitionrx's (VNRX) quarterly Other financing activities came in at $28577.0 in Q4 2025, up 29060.2% on a QoQ basis from $98.0 in Q3 2020.

Volitionrx (VNRX) Other financing activities (2019 - 2025) Analysis & Trends

Volitionrx (VNRX) has 3 years of Other financing activities data on file, last reported at $28577.0 in Q4 2025.

Quarterly Other financing activities changed N/A year-over-year to $28577.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28675.0 (up 29160.2% YoY) and the FY2025 annual result came in at $5.8 million, changed N/A from the prior year.
Other financing activities improved to $28577.0 in Q4 2025, from $98.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $28577.0 in Q4 2025 to a low of $28577.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Volitionrx	1.19 Mn	-1.60 Mn	-

Download Data